Introduction
Fish oil is the most common dietary source of the long-chain marine omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), which is an important distinction from plant-based omega-3 sources such as flaxseed oil. Dogs can only convert plant-derived alpha-linolenic acid into EPA and DHA at a limited rate, so fish oil offers a direct route to clinically relevant tissue concentrations of these fatty acids rather than relying on a conversion pathway with modest efficiency. This review focuses specifically on canine research using fish oil or its marine-derived EPA and DHA components, covering joint health, skin and allergic disease, kidney health, and broader systemic effects, while noting where evidence is strongest and where it is more limited.
Joint Health: The Best-Documented Fish Oil Benefit
Vandeweerd, Coisnon, Clegg, Cambier, Pierson, Hontoir, Saegerman, Gustin, and Buczinski (2012), in a systematic review of nutraceuticals for osteoarthritis across horses, dogs, and cats, concluded that the strength of evidence was lower than omega-3 fatty acids for every nutraceutical category in dogs, a distinction that reflects specifically fish-oil-based interventions in the underlying trials. Roush, Dodd, Fritsch, Allen, Jewell, Schoenherr, Richardson, Leventhal, and Hahn (2010) conducted a multicenter veterinary practice assessment of fish oil omega-3 fatty acids on osteoarthritis in dogs and found clinical benefit, and a companion study by Roush, Cross, Renberg, Dodd, Sixby, Fritsch, Allen, Jewell, Richardson, Leventhal, and Hahn (2010) found measurable improvement in weight-bearing specifically from fish-oil-supplemented diets.
Fritsch, Allen, Dodd, Jewell, Sixby, Leventhal, Brejda, and Hahn (2010) showed that dogs fed fish oil omega-3 fatty acids required lower doses of carprofen, a commonly used NSAID, to control osteoarthritis signs, directly demonstrating a drug-sparing effect from fish oil supplementation specifically. Moreau, Troncy, Del Castillo, Bédard, Gauvin, and Lussier (2013) confirmed benefit using a veterinary therapeutic diet rich in fish-oil-derived omega-3s compared to a regular control diet in dogs with naturally occurring osteoarthritis, and Mehler, May, King, Harris, and Shah (2016) specifically tested EPA and DHA, the two principal fish oil fatty acids, finding improved clinical signs alongside measurable increases in erythrocyte membrane concentrations of these fatty acids, directly linking fish oil dosage to tissue-level change and clinical outcome.
Skin and Allergic Disease
Fish-oil-derived EPA and DHA also have a genuine, randomized-trial-level evidence base in canine atopic dermatitis. Saevik, Bergvall, Holm, Saijonmaa-Koulumies, Hedhammar, Larsen, and Kristensen (2004) found a steroid-sparing effect from essential fatty acid supplementation, including fish oil sources, in a placebo-controlled trial of 60 dogs, meaning dogs required less corticosteroid medication to control clinical signs. Popa, Pin, Remoué, Osta, Callejon, Videmont, Gatto, Portoukalian, and Haftek (2011) directly analyzed epidermal lipids in atopic dogs before and after an oral omega-6/omega-3 feed supplement and found measurable changes in skin lipid composition, while Abba, Mussa, Vercelli, and Raviri (2005) found that serum arachidonic acid, the inflammatory omega-6-derived compound fish oil is thought to help displace, was significantly reduced following polyunsaturated fatty acid supplementation in atopic dogs.
Mueller, Fettman, Richardson, Hansen, Miller, Magowitz, and Ogilvie (2005) confirmed that plasma and skin concentrations of polyunsaturated fatty acids shift measurably following fish-oil-derived n-3 fatty acid supplementation in dogs with atopic dermatitis, and this body of evidence collectively informed the International Task Force on Canine Atopic Dermatitis (Olivry et al., 2010), whose clinical practice guidelines include dietary fatty acid supplementation as part of standard management.
Kidney Health: A Renoprotective Effect
One of the more distinctive and specifically fish-oil-relevant findings in canine nutrition research concerns chronic kidney disease. Brown, Brown, Crowell, Barsanti, Allen, Cowell, and Finco (1998) conducted a twenty-month controlled trial in dogs with surgically induced renal insufficiency, comparing menhaden fish oil (omega-3), safflower oil (omega-6), and beef tallow (saturated fat) as the primary dietary fat source. The fish oil group showed significantly lower proteinuria and lower plasma creatinine, cholesterol, and triglyceride concentrations than the other groups, along with a significantly higher glomerular filtration rate and less renal interstitial fibrosis, glomerulosclerosis, and cellular infiltrate than the omega-6 group. Strikingly, the study found that omega-6 supplementation actively worsened renal injury relative to fish oil, while fish oil was genuinely renoprotective, one of the clearest source-specific findings in this entire body of research: it was not simply that fat type was neutral and fish oil happened to help, but that the omega-6 alternative measurably harmed kidney function by comparison.
Broader Systemic Evidence
Magalhães, Lourenço, Gregório, and Queiroga (2021) conducted a systematic review of EPA and DHA supplementation, the active compounds fish oil delivers, across neoplastic and non-neoplastic companion animal diseases, identifying twenty-three eligible studies, twenty of them in dogs. They found therapeutic benefit not only in osteoarthritis but also in canine allergic dermatitis, haircoat disorders, keratoconjunctivitis sicca (dry eye), and valvular heart disease, indicating that fish oil's anti-inflammatory and membrane-modulating mechanisms have relevance across multiple organ systems rather than being limited to a single condition.
Quality and Practical Considerations
Fish oil's benefits in the studies above depend on the product actually delivering intact, unoxidized EPA and DHA to the animal. Marine oils are inherently prone to oxidation and rancidity, particularly with poor storage, heat exposure, or low-quality processing, and oxidized fish oil is both less biologically active and potentially irritating to the gastrointestinal tract. This is a practical formulation and storage consideration rather than a finding from a specific canine trial identified in this review, but it follows directly from the chemistry of long-chain polyunsaturated fats and is worth stating plainly: a fish oil product's real-world benefit depends on freshness and quality control, not just the EPA and DHA content printed on the label.
Practical Takeaways
Fish oil has an unusually strong, source-specific evidence base in dogs for osteoarthritis, including a demonstrated NSAID-sparing effect, and genuine randomized-trial support for atopic dermatitis, including a steroid-sparing effect. The renal insufficiency research is particularly notable because it directly compared fish oil against an omega-6 alternative and found fish oil protective while the omega-6 source was actively harmful, a more source-specific conclusion than most canine nutraceutical research offers. Product quality and freshness are practical prerequisites for realizing these benefits, independent of dose.
Conclusion
Fish oil, as a concentrated source of EPA and DHA, has some of the best-documented benefits of any canine nutraceutical: strong support for osteoarthritis management, genuine randomized-trial evidence for atopic dermatitis, and a distinctive renoprotective effect in dogs with chronic kidney disease that stands in direct, unfavorable contrast to an omega-6 alternative. This combination of joint, skin, and kidney evidence, along with broader systemic findings, makes fish oil one of the more defensible nutraceutical recommendations in canine nutrition, provided the product used is fresh and well-preserved.
References
Abba, C., Mussa, P. P., Vercelli, A., & Raviri, G. (2005). Essential fatty acids supplementation in different-stage atopic dogs fed on a controlled diet. Journal of Animal Physiology and Animal Nutrition, 89(3–6), 203–207. https://doi.org/10.1111/j.1439-0396.2005.00541.x
Brown, S. A., Brown, C. A., Crowell, W. A., Barsanti, J. A., Allen, T., Cowell, C., & Finco, D. R. (1998). Beneficial effects of chronic administration of dietary omega-3 polyunsaturated fatty acids in dogs with renal insufficiency. Journal of Laboratory and Clinical Medicine, 131(5), 447–455. https://doi.org/10.1016/s0022-2143(98)90146-9
Fritsch, D. A., Allen, T. A., Dodd, C. E., Jewell, D. E., Sixby, K. A., Leventhal, P. S., Brejda, J., & Hahn, K. A. (2010). A multicenter study of the effect of dietary supplementation with fish oil omega-3 fatty acids on carprofen dosage in dogs with osteoarthritis. Journal of the American Veterinary Medical Association, 236(5), 535–539. https://doi.org/10.2460/javma.236.5.535
Magalhães, T. R., Lourenço, A. L., Gregório, H., & Queiroga, F. L. (2021). Therapeutic effect of EPA/DHA supplementation in neoplastic and non-neoplastic companion animal diseases: A systematic review. In Vivo, 35(3), 1419–1436. https://doi.org/10.21873/invivo.12394
Mehler, S. J., May, L. R., King, C., Harris, W. S., & Shah, Z. (2016). A prospective, randomized, double blind, placebo-controlled evaluation of the effects of eicosapentaenoic acid and docosahexaenoic acid on the clinical signs and erythrocyte membrane polyunsaturated fatty acid concentrations in dogs with osteoarthritis. Prostaglandins, Leukotrienes and Essential Fatty Acids, 109, 1–7. https://doi.org/10.1016/j.plefa.2016.03.015
Moreau, M., Troncy, E., Del Castillo, J. R., Bédard, C., Gauvin, D., & Lussier, B. (2013). Effects of feeding a high omega-3 fatty acids diet in dogs with naturally occurring osteoarthritis. Journal of Animal Physiology and Animal Nutrition, 97(5), 830–837. https://doi.org/10.1111/j.1439-0396.2012.01325.x
Mueller, R. S., Fettman, M. J., Richardson, K., Hansen, R. A., Miller, A., Magowitz, J., & Ogilvie, G. K. (2005). Plasma and skin concentrations of polyunsaturated fatty acids before and after supplementation with n-3 fatty acids in dogs with atopic dermatitis. American Journal of Veterinary Research, 66(5), 868–873. https://doi.org/10.2460/ajvr.2005.66.868
Olivry, T., DeBoer, D. J., Favrot, C., Jackson, H. A., Mueller, R. S., Nuttall, T., Prélaud, P., & International Task Force on Canine Atopic Dermatitis. (2010). Treatment of canine atopic dermatitis: 2010 clinical practice guidelines from the International Task Force on Canine Atopic Dermatitis. Veterinary Dermatology, 21(3), 233–248. https://doi.org/10.1111/j.1365-3164.2010.00889.x
Popa, I., Pin, D., Remoué, N., Osta, B., Callejon, S., Videmont, E., Gatto, H., Portoukalian, J., & Haftek, M. (2011). Analysis of epidermal lipids in normal and atopic dogs, before and after administration of an oral omega-6/omega-3 fatty acid feed supplement: A pilot study. Veterinary Research Communications, 35(8), 501–509. https://doi.org/10.1007/s11259-011-9493-7
Roush, J. K., Cross, A. R., Renberg, W. C., Dodd, C. E., Sixby, K. A., Fritsch, D. A., Allen, T. A., Jewell, D. E., Richardson, D. C., Leventhal, P. S., & Hahn, K. A. (2010). Evaluation of the effects of dietary supplementation with fish oil omega-3 fatty acids on weight bearing in dogs with osteoarthritis. Journal of the American Veterinary Medical Association, 236(1), 67–73. https://doi.org/10.2460/javma.236.1.67
Roush, J. K., Dodd, C. E., Fritsch, D. A., Allen, T. A., Jewell, D. E., Schoenherr, W. D., Richardson, D. C., Leventhal, P. S., & Hahn, K. A. (2010). Multicenter veterinary practice assessment of the effects of omega-3 fatty acids on osteoarthritis in dogs. Journal of the American Veterinary Medical Association, 236(1), 59–66. https://doi.org/10.2460/javma.236.1.59
Saevik, B. K., Bergvall, K., Holm, B. R., Saijonmaa-Koulumies, L. E., Hedhammar, A., Larsen, S., & Kristensen, F. (2004). A randomized, controlled study to evaluate the steroid sparing effect of essential fatty acid supplementation in the treatment of canine atopic dermatitis. Veterinary Dermatology, 15(3), 137–145. https://doi.org/10.1111/j.1365-3164.2004.00378.x
Vandeweerd, J. M., Coisnon, C., Clegg, P., Cambier, C., Pierson, A., Hontoir, F., Saegerman, C., Gustin, P., & Buczinski, S. (2012). Systematic review of efficacy of nutraceuticals to alleviate clinical signs of osteoarthritis. Journal of Veterinary Internal Medicine, 26(3), 448–456. https://doi.org/10.1111/j.1939-1676.2012.00901.x
